Home > Financial Ratios > WOCKHARDT

WOCKHARDT
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for WOCKHARDT
Please provide your vote to see the results

WOCKHARDT Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 67.69272.95-45.29-29.87360.87

What is the latest Core EBITDA Growth ratio of WOCKHARDT ?

The latest Core EBITDA Growth ratio of WOCKHARDT is 67.69 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202667.69
Mar2025272.95
Mar2024-45.29
Mar2023-29.87
Mar2022360.87

How is Core EBITDA Growth of WOCKHARDT Trending?

Years Core EBITDA Growth % Change
Mar2026 67.69
-75.20
Mar2025 272.95
Positive
Mar2024 -45.29
Negative
Mar2023 -29.87
Negative
Mar2022 360.87 -

Other Financial Ratios of WOCKHARDT


Compare Core EBITDA Growth ratio of peers of WOCKHARDT

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WOCKHARDT ₹32,105.1 Cr 4% 3.6% 32.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹460,696.0 Cr 0.5% -4% 15.7% Stock Analytics
DIVIS LABORATORIES ₹246,063.0 Cr 9.1% 18.2% 47.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,515.0 Cr 3.6% 3.4% 36.4% Stock Analytics
CIPLA ₹114,554.0 Cr -1.2% -3.3% -10.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,308.6 Cr -1.4% 2.9% -8% Stock Analytics


WOCKHARDT Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WOCKHARDT

4%

3.6%

32.6%

SENSEX

-0.4%

-0.5%

-5.8%


You may also like the below Video Courses